{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:08:40Z","timestamp":1780474120234,"version":"3.54.1"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11,11]]},"abstract":"<jats:p>Transcription factors E26 transformation-specific-1 (Ets-1) and Friend leukemia insertion site-1 (Fli-1) and type I interferon (IFN) have been implicated in systemic lupus erythematosus (SLE). We examined the expression of these genes in peripheral blood mononuclear cells (PBMCs) from Japanese patients with SLE and analyzed their association with SLE. We enrolled 53 Japanese patients with SLE, 42 patients with rheumatoid arthritis (RA), and 30 healthy donors (HDs) (as controls) in this study. PBMCs were collected from all participants, and the expressions of Ets-1, Fli-1, and three interferon-inducible genes (IFIGs) (interferon-inducible protein with tetratricopeptide 1 [IFIT1], interferon-inducible protein 44 [IFI44], and eukaryotic translation initiation factor 2 alpha kinase 2 [EIF2AK2]) were measured using real-time polymerase chain reaction (PCR). The relationships of each molecule with clinical symptoms, laboratory data, and treatments were analyzed. The expression of Ets-1 and Fli-1 was significantly lower in the PBMCs from patients with SLE than that in the PBMCs from patients with RA and HDs. The expression of the three IFIGs was significantly higher in the PBMCs from patients with SLE than that in the PBMCs from patients with RA and HDs. For patients with SLE, significantly positive correlations were found between Ets-1 and three IFIGs; a similar trend was observed between Fli-1 and IFIGs. IFIG expression in the PBMCs was significantly higher in patients with SLE than that in other participants, and the expression of Ets-1 and Fli-1 was positively associated with IFN expression. Therefore, it was suggested that Ets-1 and Fli-1 were associated with the pathophysiology of SLE by regulating the type I IFN pathway.<\/jats:p>","DOI":"10.1097\/md.0000000000031522","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T14:12:39Z","timestamp":1668694359000},"page":"e31522","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["The expression of Ets-1 and Fli-1 is associated with interferon-inducible genes in peripheral blood mononuclear cells from Japanese patients with systemic lupus erythematosus"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9042-4947","authenticated-orcid":false,"given":"Eiji","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"},{"name":"Department of Rheumatology, Ohta-Nishinouchi Hospital, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian K.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Yashiro-Furuya","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kanno","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus.","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.56.7.481","article-title":"Pathogenesis of systemic lupus erythematosus.","volume":"56","author":"Mok","year":"2003","journal-title":"J Clin Pathol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus.","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1002\/art.20798","article-title":"Coordinate overexpression of interferon-\u03b1-induced genes in systemic lupus erythematosus.","volume":"50","author":"Kirou","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","article-title":"Type I interferon in the pathogenesis of lupus.","volume":"192","author":"Crow","year":"2014","journal-title":"J Immunol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/BOR.0000000000000087","article-title":"Advances in understanding the role of type I interferons in systemic lupus erythematosus.","volume":"26","author":"Crow","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/art.39985","article-title":"Interferon-targeted therapy for systemic lupus erythematosus: are the trials of target?","volume":"69","author":"Msaasrotti","year":"2017","journal-title":"Arthritis Rheum"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/14397595.2018.1493909","article-title":"Emerging targets for the treatment of lupus erythematosus: there is no royal road to treating lupus.","volume":"29","author":"Yasuda","year":"2019","journal-title":"Mod Rheumatol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI124466","article-title":"Monoclonal antibody targeting BDCA2 ameliorates skin lesion in systemic lupus erythematosus.","volume":"129","author":"Furie","year":"2019","journal-title":"J Clin Invest"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S2665-9913(19)30076-1","article-title":"Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomized, controlled, phase 3 trial.","volume":"1","author":"Furie","year":"2019","journal-title":"Lancet Rheumatol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus.","volume":"382","author":"Morand","year":"2020","journal-title":"N Engl J Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14397595.2020.1812201","article-title":"Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials.","volume":"31","author":"Tanaka","year":"2021","journal-title":"Mod Rheumatol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/art.41598","article-title":"Long-term safety and efficacy on anifrolumab in adults with systemic lupus erythematosus: results of phase II open-label extension study.","volume":"73","author":"Chatham","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.autrev.2011.01.007","article-title":"The dual nature of Ets-1: focuses on the pathogenesis of systemic lupus erythematosus.","volume":"10","author":"Leng","year":"2011","journal-title":"Autiummun Rev"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10753-015-0257-3","article-title":"Fli-1, a functional factor performed in autoimmune lupus.","volume":"39","author":"Xu","year":"2016","journal-title":"Inflammation"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3892\/ijo.9.1.9","article-title":"Expression of ets family of genes in systemic lupus erythematosus and Sjogren\u2019s syndrome.","volume":"9","author":"Georgiou","year":"1996","journal-title":"Int J Oncol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.3760\/cma.j.issn.0366-6999.2010.16.025","article-title":"Expression analysis of Ets1 gene in peripheral blood mononuclear cells with systemic lupus erythematosus by real-time reverse transcription PCR.","volume":"123","author":"Li","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/intimm\/dxh295","article-title":"Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR 9, and autoimmune disease.","volume":"17","author":"Wang","year":"2005","journal-title":"Int Immunol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1128\/MCB.15.12.6961","article-title":"An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes.","volume":"15","author":"Zhang","year":"1995","journal-title":"Mol Cell Biol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.4049\/jimmunol.173.10.6481","article-title":"Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL\/lpr mice.","volume":"173","author":"Zhang","year":"2004","journal-title":"J Immunol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2249.2010.04245.x","article-title":"Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice.","volume":"162","author":"Mathenia","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ng.472","article-title":"Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus.","volume":"41","author":"Han","year":"2009","journal-title":"Nat Genet"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"e1000841","DOI":"10.1371\/journal.pgen.1000841","article-title":"Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus.","volume":"6","author":"Yang","year":"2010","journal-title":"PLoS Genet"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1084\/jem.20070994","article-title":"Ets-1 is a negative regulator of Th17 differentiation.","volume":"204","author":"Moisan","year":"2007","journal-title":"J Exp Med"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/377635a0","article-title":"Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene.","volume":"377","author":"Bories","year":"1995","journal-title":"Nature"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.immuni.2018.10.012","article-title":"The transcription factor Ets1 suppresses T follicular helper type 2 cell differentiation to halt the onset of systemic lupus erythematosus.","volume":"49","author":"Kim","year":"2018","journal-title":"Immunity"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0961203310389842","article-title":"Ets-1: a new player in the pathogenesis of systemic lupus erythematosus?","volume":"20","author":"Pan","year":"2011","journal-title":"Lupus"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"e62346","DOI":"10.1371\/journal.pone.0062346","article-title":"Fli-1 overexpression in hematopoietic progenitors deregulates T cell development and induces pre-T cell lymphoblastic leukemia\/lymphoma.","volume":"8","author":"Smeets","year":"2013","journal-title":"PLoS One"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4049\/jimmunol.181.3.1644","article-title":"The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice.","volume":"181","author":"Zhang","year":"2008","journal-title":"J Immunol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/imm.12070","article-title":"The transcription factor Fli-1 regulates monocyte, macrophage, and dendritic cell development in mice.","volume":"139","author":"Suzuki","year":"2013","journal-title":"Immunology"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.38818","article-title":"A critical role of the transcription factor fli-1 in murine lupus development by regulation of interleukin-6 expression.","volume":"66","author":"Sato","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4049\/jimmunol.1302779","article-title":"The Fli-1 transcription factor regulates the expression of CCL5\/RANTES.","volume":"193","author":"Lennard Richard","year":"2014","journal-title":"J Immunol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clim.2012.09.006","article-title":"Fli-1 transcription factor affects glomerulonephritis development by regulating the expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney.","volume":"145","author":"Suzuki","year":"2012","journal-title":"Clin Immunol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised the criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative.","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R37-20250504","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000.","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"R38-20250504","first-page":"1205","article-title":"Confirmation of five novel susceptibility loci for systemic lupus erythematosus (SLE) and integrated network analysis of 82 SLE susceptibility loci.","volume":"26","author":"Molineros","year":"2017","journal-title":"Hum Mol Genet"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/annrheumdis-2020-219209","article-title":"Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus.","volume":"80","author":"Yin","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/ar3844","article-title":"The genetics of lupus: a functional perspective.","volume":"14","author":"Guerra","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/BOR.0b013e32835c7e32","article-title":"The interferon signature in autoimmune diseases.","volume":"25","author":"R\u00f6nnblom","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1074-7613(00)80638-X","article-title":"The Ets-1 transcription factor is required for the development of natural killer cells in mice.","volume":"9","author":"Barton","year":"1998","journal-title":"Immunity"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1038\/s41467-021-24609-4","article-title":"Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease.","volume":"12","author":"Ban","year":"2021","journal-title":"Nat Commun"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/tan.12349","article-title":"Gene-gene interactions of IRF5, STAT4, IKZF1 and ETS1 in systemic lupus erythematosus.","volume":"83","author":"Dang","year":"2014","journal-title":"Tissue Antigens"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.1997.17.1","article-title":"Specific binding of the ETS-domain protein to the interferon-stimulated response element.","volume":"17","author":"Rutherford","year":"1997","journal-title":"J Interferon Cytokine Res"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.4049\/jimmunol.1203301","article-title":"Autoantibody induction by DNA-containing immune complexes require HMGB1 with the TLR2\/microRNA-155 pathway.","volume":"190","author":"Wen","year":"2013","journal-title":"J Immunol"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"25143","DOI":"10.1074\/jbc.M201628200","article-title":"Ets-1 regulates fli-1 expression in endothelial cells. Identification of ETS binding sites in the fli-1 gene promoter.","volume":"277","author":"Leli\u00e8vre","year":"2002","journal-title":"J Biol Chem"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/art.41685","article-title":"Camptothecin and topotecan, inhibitors of transcription factor Fli-1 and topoisomerase, markedly ameliorate lupus nephritis in (NZB \u00d7 NZW)F1 mice and reduce the production of inflammatory mediators in human renal cells.","volume":"73","author":"Wang","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/eji.201646315","article-title":"Acetylation impacts Fli-1-driven regulation of granulocyte colony-stimulating factor.","volume":"46","author":"Lennard Richard","year":"2016","journal-title":"Eur J Immunol"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1101\/gr.265249.120","article-title":"Multi-cell type gene coexpression network analysis reveals coordinated interferon response and cross-cell type correlation in systemic lupus erythematosus.","volume":"31","author":"Panwar","year":"2021","journal-title":"Genome Res"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identified a subgroup of systemic lupus erythematosus patients with distinct serological features and active disease.","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/art.23216","article-title":"Association of IRF5 polymorphisms with systemic lupus erythematosus in Japanese population: support for a crucial role of intron 1 polymorphisms.","volume":"58","author":"Kawasaki","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1002\/art.11225","article-title":"Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.","volume":"48","author":"Blomberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/art.23186","article-title":"Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18.","volume":"58","author":"Tucci","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3389\/fimmu.2018.00755","article-title":"Dendritic cells in early drug na\u00efve rheumatoid arthritis.","volume":"9","author":"Cooles","year":"2018","journal-title":"Front Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:04:02Z","timestamp":1746335042000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":56,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031522","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]}}}